Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Grounded Lithium Announces Robust $4.5 Million Budget Funded by Denison Mines for the Kindersley Lithium Project
-
Alithya publishes third ESG Report
-
Aardvark Therapeutics Expands Management Team with Two Key Hires
-
OCI Global Announces Repurchase of OCI Methanol Minorities
-
Chang Robotics Named One of Fast Company's 2024 Best Workplaces for Innovators and Finalist in Artificial Intelligence & Robotics Category
-
My Place Group: Fall in Love with your NEW PLACE in Ohio City
-
I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer
-
InMode Announces Share Repurchase Program of Up to 7.68 Million Shares
-
Sharebite Ranks No. 35 on Fast Company's Annual List of 100 Best Workplaces for Innovators
-
"Dermatologic Surgery" Journal Publishes Special Issue on Neuromodulators
-
Guardian Capital Announces Fund Termination
-
Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations
-
Enghouse Networks Expands Footprint In Sports Streaming, Advertising And Monetization With New Product Capabilities
-
Cognyte Reports Strong Second Quarter Fiscal 2025 Financial Results
-
CMV (Cytomegalovirus) and HIV in Semen Testing During the COVID19 Emergency Era reveals that current anti-viral therapies do not eliminate HIV in the semen of HIV-infected men
-
Crowds of 80,000 Gather for Worship at Shincheonji Church of Jesus
-
People facing hunger call for change: Feeding America report highlights unity needed to end hunger
-
Volta Insite (US) Inc. Achieves UL Listing for VI Modules AC002.03.001 and AC003.03.01
-
CI Global Asset Management Launches Global Equity Fund and ETF Mandates Powered by Quality, Dividends and Growth
-
Los Lobos to headline Concert for Justice in benefit of Evanston's Moran Center
-
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
-
Ryan Acquires Property Tax Advisors LLC
-
United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
-
Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease
-
Veritone to Showcase AI Solutions for Content Monetization, Advertising Performance and Localization at IBC2024 in Amsterdam
-
Aviceda Therapeutics Announces Addition of Erin Lavelle to Board of Directors
-
Delta-Fly Pharma Inc.: Phase I/II Combo-study of DFP-10917 with Venetoclax in Patients with AML Initiates Enrollment of Patients
-
Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates
-
Upbound Group, Inc. Announces New Independent Director Charu Jain
-
Rocket Lab Appoints Chief Operations Officer to Support Company Growth
-
MINT Strengthens its Board of Directors with the Addition of a Global Technology Executive
-
SolarEdge Unveils Next Generation All-in-One Home Solar + Storage Solution at RE+ 2024
-
D-Wave to Showcase the Impact of Quantum-Powered Optimization at Info-Tech LIVE
-
Laser Photonics Shares Concept Animation of Next-Gen CleanTech Robotic Cell
-
Matternet Receives First Light UAS Operator Certificate from Swiss Federal Office of Civil Aviation for Advanced Drone Operations
-
Xcell Biosciences Advances Labcorp Collaboration with Novel Platform for Automated Cell and Gene Therapy Manufacturing
-
Fervo Energy’s Record-Breaking Production Results Showcase Rapid Scale Up of Enhanced Geothermal
-
Meketa Capital Launches Infrastructure Fund on Schwab’s Mutual Fund Marketplace
-
Oppenheimer Names Aaron Stowell Managing Director and Branch Manager of Atlanta Office
-
World Wide Technology Named One of Fast Company’s 100 Best Workplaces for Innovators
-
Incendia Therapeutics Enrolls First Patient in Phase 1c Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor
-
MSC Income Fund, Inc. Files Definitive Proxy Statement in Connection with Potential Listing of its Shares on a National Securities Exchange
-
Stoke Therapeutics Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition and Behavior That Support the Potential for Disease Modifica
-
Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
-
BCN to Participate in September 11 National Day of Service and Remembrance
-
The Greenery Picks Rootstock ERP and Salesforce to Harvest Growth and Reap Operational Efficiencies
-
edatanetworks Inc. Augmented Reality Patent Approved by USPTO
-
Wills Group Selects SymphonyAI Connected Retail to Create Engaging, High-Quality Shopper Experience
-
KalVista Pharmaceuticals to Participate in the 2024 Cantor Global Healthcare Conference
-
Algorhythm Holdings Announces Changes to Board of Directors
